Study to Allow Access to Nilotinib for Patients Who Are on Nilotinib Treatment in a Novartis-sponsored Study
Novartis
Novartis
Deciphera Pharmaceuticals, LLC
Dong-A ST Co., Ltd.
Amneal Pharmaceuticals, LLC
INSYS Therapeutics Inc
Chong Kun Dang Pharmaceutical
Assistance Publique - Hôpitaux de Paris